Pioneer Group, a leader in life science infrastructure and venture-building, has appointed industry leader, Chris Walters, as Portfolio Director and European Acquisitions Lead. Chris brings extensive experience in life sciences real estate, supported by a strong network of relationships across academia, research institutes, public sector bodies and real estate capital. His appointment will play a pivotal role in advancing Pioneer’s growth strategy and strengthening its position as a global leader in science-focused commercial real estate. Commenting on his appointment, Chris said: “I am…

Nominations are now officially open for the inaugural Private Business Awards Sponsored by BDO, the awards serve to celebrate the UK’s mid-sized businesses that are driving UK economic growth The Private Business Awards 2025, sponsored by BDO, has officially launched, with nominations now open to all UK registered private or PE-backed businesses with a turnover of £50m-£300m. The inaugural awards programme, which serves to celebrate the mid-sized businesses that drive UK economic growth, aims to recognise the very best of private business in the UK. The Private…

Read February eNews here. Featuring: ✅ Is Investor Love for the Sector Returning This February? by Tony Jones ✅ EY Firepower Report: Life Sciences Dealmaking – Trends In 2025 ✅ UK Life Sciences: Funding, Collaboration and AI Adoption Will Be Key to Success in 2025 by RSM's Laragh Jeanroy and Graham Bond ✅ Life Sciences: a Structured Approach to Implementing Pay Transparency Practices by Aon ✅ Life Sciences: The Impact of the CSRD Legislation on Executive Incentives by Aon ✅ 5 Reasons to Sponsor the One Nucleus Highlights magazine ✅ Horizon Europe Funding Survey from Innovate UK ✅ How One…

All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection 24 replicates to support simultaneous assessment of up to eight conditions per kit Cambridge, UK, 04 February 2025: CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® DILI assay kit: Human 24. Built upon CN Bio’s human-derived and highly characterized liver microphysiological…

London, February 4, 2025 – Coulter Partners, the global expert in building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Our Future Health and is pleased to announce the placement of Andrew Miles, as Chief Business Officer (CBO).Our Future Health is an ambitious collaboration between the public, charity and private sectors to build the UK’s largest ever health research program – bringing people together to develop new ways to prevent, detect and treat disease such as dementia, cancer, diabetes…

We’re delighted to announce that Samuel Atack will be stepping into the role of Operations Director at Stevenage Bioscience Catalyst on 1st April 2025 when current Operations Director Dave Mudd retires. After four years as Facilities & Estates Manager, Sam has been instrumental in delivering major facilities-led projects while supporting and developing the Operations team. His expertise includes Health & Safety, ESG, strategic oversight, and project management. With a strong focus on operational excellence, sustainability, and stakeholder engagement, Sam is passionate about driving…

Minister Vallance underlines how Oxford-Cambridge corridor ambitions can boost whole UK  Science Minister Vallance today visited semiconductors and life sciences firms in Cambridgeshire, following his appointment as Oxford-Cambridge Innovation Champion In new role, Vallance will convene local, national and business leaders to deliver coordinated action that drives investment, pulls in investment and unleashes growth Vallance will build on national responsibilities as Science Minister to strengthen connections between OxCam and wider UK, so this region is an economic engine for the…

Calling all oncology startup founders! Fancy winning £50,000-worth of resources like lab space and tailored support? Last chance to apply for the fantastic Discovery Spark accelerator programme: 💡 Work with expert mentors to refine your strategy and storytelling🌐 Join a network of founders and industry leaders 🏆 Compete for resources like free lab space and tailored support worth over £50,000 Apply now: https://lnkd.in/ew_wSHgf

Search HighlightsRecent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech. This quarter’s successful placements include:Function, Focus area, LocationCEO, Antibody-based therapies, USCEO, Oncolytic viruses, UKCEO, Oncology biotech, SpainChief Financial Officer, Nanotechnology diagnostics, SwitzerlandChief Innovation Officer, Connected medical devices, FranceChief R&D Officer, Gene-encoded drug discovery, UKChief Commercial Officer, Computational chemistry, UKChief…

London, January 28, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for ICR Healthcare and is pleased to announce the placement of Sarah Elton-Farr as Partner, effective April 2025. ICR Healthcare is a leading global strategic communications and investor relations advisory firm specializing in the healthcare sector. Sarah Elton-Farr joins the firm's London office, complementing other recent senior-level appointments and promotions, and…